Rifapentine - Sanofi
At a glance
- Drug Originator sanofi-aventis
- Drug Class Antituberculars; Heterocyclic compounds; Piperazines; Rifamycins
- Mechanism of Action DNA-directed RNA polymerase inhibitors
- USA Patent Applicants SANOFI AVENTIS US
- NDAs 1
- Patent Applications 2,988
Table of Contents

Disclaimer